Active COVID-19 cases decrease further

…only 3 new cases recorded

The active cases of COVID-19 in Guyana are rapidly decreasing as more patients recover and as of Saturday, these numbers decreased to 290.
The Health Ministry’s dashboard showed that only three new cases were detected in one day – all of which were from Region Four (Demerara-Mahaica). Now, the number of confirmed cases is at 6351 with 164 deaths.
There are four persons in the Intensive Care Unit, 10 in institutional isolation, 279 in home isolation and 21 in institutional quarantine. From the 3281 males and 3070 females that tested positive, 5894 have recovered.
A breakdown showed that 937 cases were confirmed in Region One (Barima-Waini), 189 in Region Two (Pomeroon-Supenaam), 452 in Region Three (Essequibo Islands-West Demerara), 2716 in Region Four (Demerara-Mahaica), 100 in Region Five (Mahaica-Berbice), 304 in Region Six (East Berbice-Corentyne), 542 in Region Seven (Cuyuni-Mazaruni), 197 in Region Eight (Potaro-Siparuni), 396 in Region Nine (Upper Takutu-Upper Essequibo) and 518 in Region 10 (Upper Demerara-Berbice).
The Pan American Health Organisation surmised at the end of 2020 that the COVID-19 pandemic swept through every country in the Americas in 2020, infecting more than 35 million people and causing some 850,000 deaths.
“Globally, COVID-19 affected 216 countries and territories, causing more than 80 million cases and 1.7 million deaths worldwide. The Americas was the most affected continent in a context of large inequities,” a statement analysed.
At the start of the pandemic, PAHO said it activated an organisation-wide response through regional and country incident management system teams. The Organisation worked with countries to support their surveillance, testing and laboratory capacity; and prepare and strengthen healthcare services, infection prevention control, clinical management, and risk communication.
PAHO focused on helping countries rapidly detect cases, protect their health workers, reduce transmission, and save lives, providing training, logistical support, vital equipment and supplies, and emergency planning. To complement PAHO resources in 27 country offices, personnel and supplies were mobilised to train national health authorities, support national emergency plans, and assess reorganisation of health services.
“The global scientific community raced to identify and assess the efficacy of potential therapeutics for caring for persons sickened by COVID-19. To help countries navigate the deluge of information, PAHO reviewed findings from over 1700 clinical trials and 58 therapeutic options to enable health authorities to take evidence-backed decisions for patient care. In addition, 111 technical guidelines and recommendations were developed or tailored to the Americas from WHO documents.”
Global partnerships like the COVAX Facility are also pooling resources to ensure that countries have equal access to safe and effective vaccines under the same timelines. PAHO’s Revolving Fund, through which 41 countries and territories pool their resources to procure high-quality vaccines, syringes and related supplies for their populations at the lowest price, is expected to play a significant role in the COVID-19 fight.